<DOC>
	<DOCNO>NCT00006247</DOCNO>
	<brief_summary>RATIONALE : SU5416 may stop growth brain cancer cell stop blood flow tumor . PURPOSE : Phase I trial study safety deliver SU5416 child recurrent progressive brain tumor .</brief_summary>
	<brief_title>SU5416 Treating Children With Recurrent Progressive Brain Tumors</brief_title>
	<detailed_description>OBJECTIVES : I . Determine qualitative quantitative toxicity SU5416 pediatric patient recurrent progressive brain tumor . II . Determine acute chronic dose-limiting toxicity cumulative toxicity regimen patient . III . Determine maximum tolerate dose pharmacokinetics regimen patient population . IV . Determine effect hepatic enzyme-inducing drug , anticonvulsant agent , pharmacokinetics regimen patient . V. Determine efficacy , preliminary manner , regimen patient . OUTLINE : This dose-escalation , multicenter study . Patients stratify accord concurrent use enzyme-inducing anticonvulsant drug ( yes v drug modest-induction drug ) . Patients receive SU5416 IV 1 hour twice week 6 week . Treatment repeat every 6 week 17 course ( approximately 2 year ) absence unacceptable toxicity disease progression . Cohorts 3-6 patient stratum receive escalating dos SU5416 maximum tolerate dose ( MTD ) determine . The MTD define dose precede 2 3 2 6 patient experience dose-limiting toxicity . Patients follow every 3 month 1 year , every 6 month 4 year , annually 5 year . PROJECTED ACCRUAL : A total 50 patient ( 25 per stratum ) accrue study .</detailed_description>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Semaxinib</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically prove malignant recurrent progressive brain tumor initial presentation time recurrence progression standard curative therapy exist Histologic verification brainstem glioma may waive Bone marrow involvement allow PATIENT CHARACTERISTICS : Age : 21 Performance status : Karnofsky 60100 % Life expectancy : More 8 week Hematopoietic : Absolute neutrophil count great 1,000/mm3* Platelet count great 75,000/mm3* Hemoglobin great 9 g/dL *Transfusion independent Hepatic : Bilirubin normal age SGOT SGPT less 2.5 time normal age PT/PTT great 1.2 time upper limit normal Albumin great 3 g/dL No overt hepatic disease Renal : Creatinine great 1.5 time normal age OR Glomerular filtration rate great 70 mL/min No overt renal disease Cardiovascular : No deep venous arterial thrombosis within past 3 month No history myocardial infarction , severe unstable angina , severe peripheral vascular disease No overt cardiac disease No prior cerebral bleeds Pulmonary : No pulmonary embolism within past 3 month No overt pulmonary disease Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No known allergy paclitaxel agent us Cremophor EL No uncontrolled infection Neurological deficit allow stable least 1 week prior study Greater 3rd percentile weight height PRIOR CONCURRENT THERAPY : Biologic therapy : More 6 month since prior bone marrow transplantation More 1 week since prior growth factor ( ) Chemotherapy : At least 3 week since prior myelosuppressive chemotherapy ( 6 week nitrosoureas ) recover Endocrine therapy : Concurrent dexamethasone allow dose stable least 1 week prior study Radiotherapy : More 3 month since prior craniospinal irradiation great 24 Gy More 3 month since prior total body irradiation More 2 week since prior focal irradiation symptomatic metastatic sit No prior stereotactic radiosurgery Concurrent total body irradiation allow Surgery : See Radiotherapy Other : No concurrent anticancer experimental drug therapy Concurrent anticonvulsant drug allow</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>childhood craniopharyngioma</keyword>
	<keyword>childhood central nervous system germ cell tumor</keyword>
	<keyword>childhood oligodendroglioma</keyword>
	<keyword>childhood choroid plexus tumor</keyword>
	<keyword>childhood grade I meningioma</keyword>
	<keyword>childhood grade II meningioma</keyword>
	<keyword>childhood grade III meningioma</keyword>
	<keyword>recurrent childhood cerebellar astrocytoma</keyword>
	<keyword>recurrent childhood cerebral astrocytoma</keyword>
	<keyword>recurrent childhood medulloblastoma</keyword>
	<keyword>recurrent childhood visual pathway hypothalamic glioma</keyword>
	<keyword>recurrent childhood ependymoma</keyword>
</DOC>